0001209191-23-060006.txt : 20231229
0001209191-23-060006.hdr.sgml : 20231229
20231229163336
ACCESSION NUMBER: 0001209191-23-060006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231229
FILED AS OF DATE: 20231229
DATE AS OF CHANGE: 20231229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kobayashi Ken
CENTRAL INDEX KEY: 0002003383
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40881
FILM NUMBER: 231528136
MAIL ADDRESS:
STREET 1: 321 HARRISON AVENUE
STREET 2: 11TH FLOOR, SUITE 1
CITY: BOSTON
STATE: MA
ZIP: 02118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pyxis Oncology, Inc.
CENTRAL INDEX KEY: 0001782223
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831160910
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 HARRISON AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02118
BUSINESS PHONE: (617) 221-9059
MAIL ADDRESS:
STREET 1: 321 HARRISON AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02118
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-29
0
0001782223
Pyxis Oncology, Inc.
PYXS
0002003383
Kobayashi Ken
C/O PYXIS ONCOLOGY, INC.
321 HARRISON AVENUE
BOSTON
MA
02118
0
1
0
0
Chief Medical Officer
0
Stock Option (Right to Buy)
1.80
2023-12-29
4
A
0
443514
0.00
A
2033-12-29
Common Stock
443514
443514
D
Stock Option (Right to Buy)
1.80
2023-12-29
4
A
0
110878
0.00
A
2033-12-29
Common Stock
110878
110878
D
The shares subject to this option will vest over four years, with 25% vesting on November 27, 2024 and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates.
The shares subject to this option will vest upon the achievement of certain clinical milestones related to data disclosure for PYX-201.
/s/ Pamela Connealy, Attorney-in-Fact for Ken Kobayashi
2023-12-29